Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.
作者信息
SARWER-FONER G J
出版信息
Can Med Assoc J. 1960 Aug 13;83(7):312-8.
Abstract
摘要
相似文献
1
Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.
Can Med Assoc J. 1960 Aug 13;83(7):312-8.
2
A survey of drug-induced extrapyramidal reactions.
JAMA. 1961 Mar 25;175:1054-60. doi: 10.1001/jama.1961.03040120016004.
3
Phenothiazine ataraxics. Extrapyramidal reactions.
Calif Med. 1960 Jul;93(1):24-8.
4
Extrapyramidal side effects of trifluoperazine.
Proc Staff Meet Mayo Clin. 1961 May 24;36:268-70.
5
Treatment of drug-induced extrapyramidal symptoms. (A comparative study of three antiparkinson agents).
Dis Nerv Syst. 1960 Feb;21:79-81.
6
Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
Compr Psychiatry. 1962 Oct;3:292-6. doi: 10.1016/s0010-440x(62)80035-2.
7
Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine.
JAMA. 1961 Sep 9;177:665-70. doi: 10.1001/jama.1961.03040360001001.
8
An extrapyramidal reaction to triflupromazine: case report.
J Am Osteopath Assoc. 1961 Dec;61:296-7.
9
Extrapyramidal symptoms of triflupromazine, mepazine, prochlorperazine.
Dis Nerv Syst. 1959 Dec;20:569-71.
10
[Oxygen in the therapy of extrapyramidal syndromes induced by neuroleptics. Practical and theoretical importance].
Ann Med Psychol (Paris). 1962 Apr;120(1):759-65.
引用本文的文献
1
High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.
Psychopharmacology (Berl). 1980 Jan;67(1):17-23. doi: 10.1007/BF00427590.
2
Ethnicity and psychopharmacology.
Cult Med Psychiatry. 1986 Jun;10(2):151-65. doi: 10.1007/BF00156581.
3
Acute dystonia induced by neuroleptic drugs.
Psychopharmacology (Berl). 1986;88(4):403-19. doi: 10.1007/BF00178501.
4
Pharmacological characterization of tardive dyskinesia.
Psychopharmacology (Berl). 1977 Aug 31;54(1):1-8. doi: 10.1007/BF00426532.
本文引用的文献
1
Depressive states and drugs. II. The study of phenelzine dihydrogen sulfate (nardil) in open psychiatric settings.
Can Med Assoc J. 1959 Dec 15;81(12):991-6.
2
Clinical investigation of trifluoperazine (stelazine) in open psychiatric settings.
Can Med Assoc J. 1959 Nov 1;81(9):717-23.
3
[Occurrence and interpretation of psychomotor parkinsonism in megaphen or largactil prolonged therapy].
Nervenarzt. 1954 Dec 20;25(12):486-92.
4
Depressive states and drugs; a study of the use of imipramine tofranil in open psychiatric settings.
Med Serv J Can. 1959 Jun;15(6):359-82.
5
[Hysterical states of medicinal origin].
Can Psychiatr Assoc J. 1958 Jul;3(3):132-44. doi: 10.1177/070674375800300306.
6
The clinical investigation of pacatal in open psychiatric settings.
Can Med Assoc J. 1957 Sep 1;77(5):450-9.
7
Psychoanalytic theories of activity-passivity conflicts and of the continuum of ego defenses; experimental verification, using reserpine and chlorpromazine.
AMA Arch Neurol Psychiatry. 1957 Oct;78(4):413-8. doi: 10.1001/archneurpsyc.1957.02330400087011.
8
Pharmacotherapeutic evaluation and the psychiatric setting.
AMA Arch Neurol Psychiatry. 1956 Apr;75(4):362-70. doi: 10.1001/archneurpsyc.1956.02330220026003.
9
Use of reserpine in disturbed psychotic patients.
Am J Psychiatry. 1956 Mar;112(9):684-91. doi: 10.1176/ajp.112.9.684.
10
The use of reserpine in an open psychiatric setting.
Can Med Assoc J. 1955 Aug 1;73(3):187-91.
Zotero 插件